Skip to main content
OpenTrials
Completed

NCT Number: NCT04865562

Hormones and Decision Making

An investigation of the neuropsychological processes underlying ethical decision making.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–25 year

Sex eligibility

Male

Study type

Interventional

Phase

Phase 4

Primary location

Robert Josephs

Austin, Texas, 78712-1050, United States

About this study

This study will investigate the influence of reward sensitivity on cheating behavior via experimental manipulation of reward sensitivity using testosterone.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • males between 18 and 25

Exclusion criteria

  • recruitment will be limited to male participants between 18 and 25 years who have no current conditions that would preclude the use of testosterone. Specific exclusion criteria are:
  • women of all ages
  • males younger than 18 years and older than 25 years
  • self-report discomfort with ingestion of testosterone for the purpose of this study
  • body mass index lower than 18 or higher than 27
  • prior diagnosis of major depression, posttraumatic stress disorder, phobia, anxiety disorder, or other psychiatric conditions
  • first-degree relatives diagnosed with a psychiatric disorder
  • presence of a medical condition that would preclude the use of testosterone
  • use of medications that would preclude the use of testosterone
  • consumption of more than 5 cigarettes a day
  • current use of testosterone enhancing products, such as gels, creams, and injections

Treatment and study plan

testosterone propionate

Drug

1mg/0.1mL solution, to be administered intranasally

Other names: Testovis

0.5% cholorbutanol, saline

Drug

125 mg 0.5% cholorbutanol, 50mg saline

Primary outcomes

  1. Measure of ethical behavior - Cheating rate defined as the Average number of 'heads' coin flips participants claim to have obtained

    Time frame: 90 minutes

    drug administration following by behavioral outcome. Specifically, participants will have the opportunity to predict the outcome of a series of coin flips. To obtain a measure of ethical behavior, participants will have the opportunity to cheat by over-reporting their prediction accuracy.

Sponsors and collaborators

Lead sponsor

University of Texas at Austin

Other

Registry information

Important dates

Study start
2015
Primary completion
2016
Study completion
2016
First posted
Apr 29, 2021
Registry last updated
Apr 29, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.